Image

North America Infusion Pumps Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • May 2022
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50
  • Healthcare
  • Upcoming Report
  • May 2022
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

North America Infusion Pumps Market, By Type (Ambulatory Pumps, Volumetric Pumps, Syringe Pumps and Accessories), By Application (Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics) and End User (Hospitals & Clinics, Ambulatory Surgical Centers and Homecare) – Industry Trends and Forecast to 2029

North America Infusion Pumps Market

Market Analysis and Size

During surgeries, infusion pumps are used to deliver pain medication through a catheter to a specific portion of the body. Infusion pumps can deliver pain relief in a focused and consistent manner. When other techniques fail or the patient requires long-term medications or fluids, they are used. Patients are discharged for ambulatory recovery on oral analgesic control after plastic surgical operations such as liposuction, abdominoplasty, and mammoplasty. On the other hand, Anesthesiologists have begun to use infusion pumps to establish effective analgesic management in outpatient settings. These pumps deliver and maintain consistent plasma concentrations on a continual basis.

Data Bridge Market Research analyses that the infusion pumps market which was USD 13.2 billion in 2021, would rocket up to USD 28.30 billion by 2029, and is expected to undergo a CAGR of 10.0% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Infusion pumps are medical devices that used to deliver fluids or solutions for medical problems into the patient's body in precise amounts. Infusion pumps are essential because they limit the risk of medical error and are utilized in essential medical situations, such as those involving the risk of mortality.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Ambulatory Pumps, Volumetric Pumps, Syringe Pumps and Accessories), By Application (Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics) and End User (Hospitals & Clinics, Ambulatory Surgical Centers and Homecare)

Countries Covered

U.S., Canada and Mexico in North America

Market Players Covered

BD (US), Baxter (US), Braun Medical Inc (Germany), ICU Medical (US), Fresenius Kabi South Africa (Pty) Ltd (Germany), Smiths Medical (US), Medtronic (Ireland), Moog Inc. (US), AVNS (US), NIPRO (Japan), Terumo Corporation (Japan), Insulet Corporation (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care Inc. (US), JMS Co., Ltd. (Japan), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Zyno Medical LLC (US), Roche Diagnostics (Switzerland), Teleflex, Inc. (US), Mindray Medical International Limited (China)

Market Opportunities

  • Increasing incidence of chronic diseases
  • Increasing number of surgical procedures

Infusion Pumps Market Dynamics

Drivers

  • Rising geriatric population and increase in number of patients

In the projection period of 2022 to 2029, diseases such as diabetes caused by an unhealthy lifestyle are predicted to accelerate market growth. Furthermore, the market's expansion would be aided by an increase in demand for accurate diagnosis. Furthermore, increasing research and development activities and advancements in medical technology are expected to provide a slew of new opportunities that will impact the infusion pump market's growth from 2022 to 2029.

  • Rising adoption of insulin pumps

The insulin infusion pumps market in North America is being driven by the growth of services such as clinics, infusion centres, and infusion pharmacies. Infusion pumps are in high demand from infusion centres, nursing homes, and geriatric care centres due to the increased emphasis on cost-effectiveness and patients' need for specialised medical care in or near their homes.

  • Increasing Incidence of Chronic Diseases

The growing elderly population around the world, demand for infusion pumps has been increasing in the global market. This pattern can be explained by the fact that older persons typically require medications that are given intravenously rather than orally.

Opportunities

The rising incidence of chronic diseases and the increasing number of surgical procedures performed are driving the expansion of the infusion pump market. However, frequent infusion pump product recalls and strict regulatory restrictions are expected to have a negative impact on market growth. The development of low-cost pen needles, on the other hand, is expected to boost the growth of the North American infusion pump market in the future years.

Restraints/Challenges

  • Product recalls

Critical fluids, including high-risk drugs, are administered by infusion pumps. Errors in the use of these devices can cause serious damage or even death to patients. According to the Institute of Medicine in the United States, approximately 1.5 million patients are affected by pharmaceutical errors each year, with each Potential Adverse Drug Event costing an average of USD 8,750. (PADE). Among medical products, infusion pumps have one of the highest recall rates. Approximately 56,000 reports of adverse events linked with the use of infusion pumps were received by the FDA between 2005 and 2009, resulting in many injuries and 710 deaths.

  • Increasing incidence of medication errors

Medication errors account for 19.4% of all adverse events, making them the most common cause of medical injury. According to the National Center for Biotechnology Information, medical errors cause up to 251,000 deaths in the United States each year, making them the third highest cause of mortality. Infusions given intravenously (IV) have been identified as a common source of pharmaceutical mistakes.

  • High Prices of Ambulatory Implantable Devices

The high cost of ambulatory implanted devices has become a major impediment to the global market for infusion pumps' growth. Furthermore, because to the constraints of the healthcare sector in these countries, the use of infusion systems is currently prohibited in a number of impoverished regions.

This infusion pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infusion pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Infusion Pumps Market

The covid-19 outbreak has generally positively impacted the infusion pump market. The pandemic's unprecedented surge in patient numbers has put a burden on healthcare systems; infusion pump assets at healthcare institutions are falling far short of meeting the growing patient numbers, heightening short-term demand. As a result, regulators are pushing for quicker approval of new product offers on the market, which will help to boost short-term prospects.

Recent Development

 30 March 2022, Pune (SEND2PRESS NEWSWIRE) — Infusion pumps are medical devices that deliver medicinal fluids into a patient's body in a controlled manner. These pumps can provide large or tiny volumes of fluids and nutrients and pharmaceuticals like insulin or other hormones, antibiotics, chemotherapeutic drugs, pain relievers, and other medications into a patient's circulatory system.

North America Infusion Pumps Market Scope

The infusion pumps market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Ambulatory Pumps
  • Enteral Pumps
  • Patient-Controlled Analgesia (PCA) Pumps
  • Insulin Pumps
  • Volumetric Pumps
  • Smart Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Accessories

Application

End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare

Infusion Pumps Market Regional Analysis/Insights

The infusion pumps market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the infusion pumps market report are U.S., Canada and Mexico in North America.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure growth Installed base and New Technology Penetration

The infusion pumps market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infusion pumps market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infusion pumps market. The data is available for historic period 2010-2020.

Competitive Landscape and Infusion Pumps Market Share Analysis

The infusion pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infusion pumps market.

Some of the major players operating in the infusion pumps market are:

  • Baxter (US)
  • Braun Medical Inc (Germany)
  • ICU Medical (US)
  • Fresenius Kabi South Africa (Pty) Ltd (Germany)
  • Smiths Medical (US)
  • Medtronic (Ireland)
  • Moog Inc. (US)
  • AVNS (US)
  • NIPRO (Japan)
  • Terumo Corporation (Japan)
  • Insulet Corporation (US)
  • Ypsomed Holding AG (Switzerland)
  • Tandem Diabetes Care Inc. (US)
  • JMS Co., Ltd. (Japan)
  • Micrel Medical Devices SA (Greece)
  • InfuTronix Solutions LLC (US)
  • Zyno Medical LLC (US)
  • Roche Diagnostics (Switzerland)
  • Teleflex, Inc. (US)
  • Mindray Medical International Limited (China)


SKU-
Why Choose Us


Frequently Asked Questions

The North America Infusion Pumps Market value is expected USD 28.30 billion by 2029.
The North America Infusion Pumps Market is projected to grow at a CAGR of 10.0% during the forecast period of 2022-2029.
On the basis of application, the North America Infusion Pumps Market is segmented into Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics.
The major players operating in the North America Infusion Pumps Market are BD (US), Baxter (US), Braun Medical Inc (Germany), ICU Medical (US), Fresenius Kabi South Africa (Pty) Ltd (Germany), Smiths Medical (US), Medtronic (Ireland), Moog Inc. (US), AVNS (US), NIPRO (Japan), Terumo Corporation (Japan), Insulet Corporation (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care Inc. (US), JMS Co., Ltd. (Japan), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Zyno Medical LLC (US), Roche Diagnostics (Switzerland), Teleflex, Inc. (US), Mindray Medical International Limited (China).